Global Canine Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Canine Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 77

Published Date: 14 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Canine Influenza Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Canine Influenza Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Canine Influenza Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Canine Influenza Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Canine Influenza Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Canine Influenza Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Canine Influenza Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Canine Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Animal Health, Zoetis and CSL Limited. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Canine Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Liquid
Powder

Market segment by Application
Home
Pet Clinic
Others

Major players covered
Merck Animal Health
Zoetis
CSL Limited

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Canine Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Canine Influenza Vaccine, with price, sales, revenue and global market share of Canine Influenza Vaccine from 2018 to 2023.
Chapter 3, the Canine Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Canine Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Canine Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Canine Influenza Vaccine.
Chapter 14 and 15, to describe Canine Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Canine Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Canine Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Liquid
1.3.3 Powder
1.4 Market Analysis by Application
1.4.1 Overview: Global Canine Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Home
1.4.3 Pet Clinic
1.4.4 Others
1.5 Global Canine Influenza Vaccine Market Size & Forecast
1.5.1 Global Canine Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Canine Influenza Vaccine Sales Quantity (2018-2029)
1.5.3 Global Canine Influenza Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Merck Animal Health
2.1.1 Merck Animal Health Details
2.1.2 Merck Animal Health Major Business
2.1.3 Merck Animal Health Canine Influenza Vaccine Product and Services
2.1.4 Merck Animal Health Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Animal Health Recent Developments/Updates
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Canine Influenza Vaccine Product and Services
2.2.4 Zoetis Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Zoetis Recent Developments/Updates
2.3 CSL Limited
2.3.1 CSL Limited Details
2.3.2 CSL Limited Major Business
2.3.3 CSL Limited Canine Influenza Vaccine Product and Services
2.3.4 CSL Limited Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CSL Limited Recent Developments/Updates

3 Competitive Environment: Canine Influenza Vaccine by Manufacturer
3.1 Global Canine Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Canine Influenza Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Canine Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Canine Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Canine Influenza Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Canine Influenza Vaccine Manufacturer Market Share in 2022
3.5 Canine Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Canine Influenza Vaccine Market: Region Footprint
3.5.2 Canine Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Canine Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Canine Influenza Vaccine Market Size by Region
4.1.1 Global Canine Influenza Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Canine Influenza Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Canine Influenza Vaccine Average Price by Region (2018-2029)
4.2 North America Canine Influenza Vaccine Consumption Value (2018-2029)
4.3 Europe Canine Influenza Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Canine Influenza Vaccine Consumption Value (2018-2029)
4.5 South America Canine Influenza Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Canine Influenza Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Canine Influenza Vaccine Consumption Value by Type (2018-2029)
5.3 Global Canine Influenza Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Canine Influenza Vaccine Consumption Value by Application (2018-2029)
6.3 Global Canine Influenza Vaccine Average Price by Application (2018-2029)

7 North America
7.1 North America Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Canine Influenza Vaccine Market Size by Country
7.3.1 North America Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Canine Influenza Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Canine Influenza Vaccine Market Size by Country
8.3.1 Europe Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Canine Influenza Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Canine Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Canine Influenza Vaccine Market Size by Country
10.3.1 South America Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Canine Influenza Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Canine Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Canine Influenza Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Canine Influenza Vaccine Market Drivers
12.2 Canine Influenza Vaccine Market Restraints
12.3 Canine Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Canine Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Canine Influenza Vaccine
13.3 Canine Influenza Vaccine Production Process
13.4 Canine Influenza Vaccine Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Canine Influenza Vaccine Typical Distributors
14.3 Canine Influenza Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Canine Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Canine Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Merck Animal Health Major Business
Table 5. Merck Animal Health Canine Influenza Vaccine Product and Services
Table 6. Merck Animal Health Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Animal Health Recent Developments/Updates
Table 8. Zoetis Basic Information, Manufacturing Base and Competitors
Table 9. Zoetis Major Business
Table 10. Zoetis Canine Influenza Vaccine Product and Services
Table 11. Zoetis Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Zoetis Recent Developments/Updates
Table 13. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 14. CSL Limited Major Business
Table 15. CSL Limited Canine Influenza Vaccine Product and Services
Table 16. CSL Limited Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CSL Limited Recent Developments/Updates
Table 18. Global Canine Influenza Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 19. Global Canine Influenza Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 20. Global Canine Influenza Vaccine Average Price by Manufacturer (2018-2023) & (USD/Dose)
Table 21. Market Position of Manufacturers in Canine Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 22. Head Office and Canine Influenza Vaccine Production Site of Key Manufacturer
Table 23. Canine Influenza Vaccine Market: Company Product Type Footprint
Table 24. Canine Influenza Vaccine Market: Company Product Application Footprint
Table 25. Canine Influenza Vaccine New Market Entrants and Barriers to Market Entry
Table 26. Canine Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Canine Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 28. Global Canine Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 29. Global Canine Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 30. Global Canine Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 31. Global Canine Influenza Vaccine Average Price by Region (2018-2023) & (USD/Dose)
Table 32. Global Canine Influenza Vaccine Average Price by Region (2024-2029) & (USD/Dose)
Table 33. Global Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 34. Global Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 35. Global Canine Influenza Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Global Canine Influenza Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Global Canine Influenza Vaccine Average Price by Type (2018-2023) & (USD/Dose)
Table 38. Global Canine Influenza Vaccine Average Price by Type (2024-2029) & (USD/Dose)
Table 39. Global Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 40. Global Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 41. Global Canine Influenza Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 42. Global Canine Influenza Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 43. Global Canine Influenza Vaccine Average Price by Application (2018-2023) & (USD/Dose)
Table 44. Global Canine Influenza Vaccine Average Price by Application (2024-2029) & (USD/Dose)
Table 45. North America Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 46. North America Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 47. North America Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 48. North America Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 49. North America Canine Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 50. North America Canine Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 51. North America Canine Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 52. North America Canine Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Europe Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 54. Europe Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 55. Europe Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 56. Europe Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 57. Europe Canine Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 58. Europe Canine Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 59. Europe Canine Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Canine Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 62. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 63. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 64. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 65. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 66. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 67. Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 68. Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 69. South America Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 70. South America Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 71. South America Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 72. South America Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 73. South America Canine Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 74. South America Canine Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 75. South America Canine Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 76. South America Canine Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 77. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 78. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 79. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 80. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 81. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 82. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 83. Middle East & Africa Canine Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 84. Middle East & Africa Canine Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 85. Canine Influenza Vaccine Raw Material
Table 86. Key Manufacturers of Canine Influenza Vaccine Raw Materials
Table 87. Canine Influenza Vaccine Typical Distributors
Table 88. Canine Influenza Vaccine Typical Customers
List of Figures
Figure 1. Canine Influenza Vaccine Picture
Figure 2. Global Canine Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Canine Influenza Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Liquid Examples
Figure 5. Powder Examples
Figure 6. Global Canine Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Canine Influenza Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Home Examples
Figure 9. Pet Clinic Examples
Figure 10. Others Examples
Figure 11. Global Canine Influenza Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Canine Influenza Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Canine Influenza Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 14. Global Canine Influenza Vaccine Average Price (2018-2029) & (USD/Dose)
Figure 15. Global Canine Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Canine Influenza Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Canine Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Canine Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Canine Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Canine Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Canine Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Canine Influenza Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Canine Influenza Vaccine Average Price by Type (2018-2029) & (USD/Dose)
Figure 30. Global Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Canine Influenza Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Canine Influenza Vaccine Average Price by Application (2018-2029) & (USD/Dose)
Figure 33. North America Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Canine Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Canine Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Canine Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Canine Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Canine Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Canine Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Canine Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Canine Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Canine Influenza Vaccine Market Drivers
Figure 74. Canine Influenza Vaccine Market Restraints
Figure 75. Canine Influenza Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Canine Influenza Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Canine Influenza Vaccine
Figure 79. Canine Influenza Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Merck Animal Health
Zoetis
CSL Limited
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Canine Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Canine Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 77

Published Date: 14 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Canine Influenza Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Canine Influenza Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Canine Influenza Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Canine Influenza Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Canine Influenza Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Canine Influenza Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Canine Influenza Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Canine Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Animal Health, Zoetis and CSL Limited. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Canine Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Liquid
Powder

Market segment by Application
Home
Pet Clinic
Others

Major players covered
Merck Animal Health
Zoetis
CSL Limited

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Canine Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Canine Influenza Vaccine, with price, sales, revenue and global market share of Canine Influenza Vaccine from 2018 to 2023.
Chapter 3, the Canine Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Canine Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Canine Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Canine Influenza Vaccine.
Chapter 14 and 15, to describe Canine Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Canine Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Canine Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Liquid
1.3.3 Powder
1.4 Market Analysis by Application
1.4.1 Overview: Global Canine Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Home
1.4.3 Pet Clinic
1.4.4 Others
1.5 Global Canine Influenza Vaccine Market Size & Forecast
1.5.1 Global Canine Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Canine Influenza Vaccine Sales Quantity (2018-2029)
1.5.3 Global Canine Influenza Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Merck Animal Health
2.1.1 Merck Animal Health Details
2.1.2 Merck Animal Health Major Business
2.1.3 Merck Animal Health Canine Influenza Vaccine Product and Services
2.1.4 Merck Animal Health Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Animal Health Recent Developments/Updates
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Canine Influenza Vaccine Product and Services
2.2.4 Zoetis Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Zoetis Recent Developments/Updates
2.3 CSL Limited
2.3.1 CSL Limited Details
2.3.2 CSL Limited Major Business
2.3.3 CSL Limited Canine Influenza Vaccine Product and Services
2.3.4 CSL Limited Canine Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CSL Limited Recent Developments/Updates

3 Competitive Environment: Canine Influenza Vaccine by Manufacturer
3.1 Global Canine Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Canine Influenza Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Canine Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Canine Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Canine Influenza Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Canine Influenza Vaccine Manufacturer Market Share in 2022
3.5 Canine Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Canine Influenza Vaccine Market: Region Footprint
3.5.2 Canine Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Canine Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Canine Influenza Vaccine Market Size by Region
4.1.1 Global Canine Influenza Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Canine Influenza Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Canine Influenza Vaccine Average Price by Region (2018-2029)
4.2 North America Canine Influenza Vaccine Consumption Value (2018-2029)
4.3 Europe Canine Influenza Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Canine Influenza Vaccine Consumption Value (2018-2029)
4.5 South America Canine Influenza Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Canine Influenza Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Canine Influenza Vaccine Consumption Value by Type (2018-2029)
5.3 Global Canine Influenza Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Canine Influenza Vaccine Consumption Value by Application (2018-2029)
6.3 Global Canine Influenza Vaccine Average Price by Application (2018-2029)

7 North America
7.1 North America Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Canine Influenza Vaccine Market Size by Country
7.3.1 North America Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Canine Influenza Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Canine Influenza Vaccine Market Size by Country
8.3.1 Europe Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Canine Influenza Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Canine Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Canine Influenza Vaccine Market Size by Country
10.3.1 South America Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Canine Influenza Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Canine Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Canine Influenza Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Canine Influenza Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Canine Influenza Vaccine Market Drivers
12.2 Canine Influenza Vaccine Market Restraints
12.3 Canine Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Canine Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Canine Influenza Vaccine
13.3 Canine Influenza Vaccine Production Process
13.4 Canine Influenza Vaccine Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Canine Influenza Vaccine Typical Distributors
14.3 Canine Influenza Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Canine Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Canine Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Merck Animal Health Major Business
Table 5. Merck Animal Health Canine Influenza Vaccine Product and Services
Table 6. Merck Animal Health Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Animal Health Recent Developments/Updates
Table 8. Zoetis Basic Information, Manufacturing Base and Competitors
Table 9. Zoetis Major Business
Table 10. Zoetis Canine Influenza Vaccine Product and Services
Table 11. Zoetis Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Zoetis Recent Developments/Updates
Table 13. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 14. CSL Limited Major Business
Table 15. CSL Limited Canine Influenza Vaccine Product and Services
Table 16. CSL Limited Canine Influenza Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CSL Limited Recent Developments/Updates
Table 18. Global Canine Influenza Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 19. Global Canine Influenza Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 20. Global Canine Influenza Vaccine Average Price by Manufacturer (2018-2023) & (USD/Dose)
Table 21. Market Position of Manufacturers in Canine Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 22. Head Office and Canine Influenza Vaccine Production Site of Key Manufacturer
Table 23. Canine Influenza Vaccine Market: Company Product Type Footprint
Table 24. Canine Influenza Vaccine Market: Company Product Application Footprint
Table 25. Canine Influenza Vaccine New Market Entrants and Barriers to Market Entry
Table 26. Canine Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Canine Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 28. Global Canine Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 29. Global Canine Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 30. Global Canine Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 31. Global Canine Influenza Vaccine Average Price by Region (2018-2023) & (USD/Dose)
Table 32. Global Canine Influenza Vaccine Average Price by Region (2024-2029) & (USD/Dose)
Table 33. Global Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 34. Global Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 35. Global Canine Influenza Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Global Canine Influenza Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Global Canine Influenza Vaccine Average Price by Type (2018-2023) & (USD/Dose)
Table 38. Global Canine Influenza Vaccine Average Price by Type (2024-2029) & (USD/Dose)
Table 39. Global Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 40. Global Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 41. Global Canine Influenza Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 42. Global Canine Influenza Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 43. Global Canine Influenza Vaccine Average Price by Application (2018-2023) & (USD/Dose)
Table 44. Global Canine Influenza Vaccine Average Price by Application (2024-2029) & (USD/Dose)
Table 45. North America Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 46. North America Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 47. North America Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 48. North America Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 49. North America Canine Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 50. North America Canine Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 51. North America Canine Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 52. North America Canine Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Europe Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 54. Europe Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 55. Europe Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 56. Europe Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 57. Europe Canine Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 58. Europe Canine Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 59. Europe Canine Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Canine Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 62. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 63. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 64. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 65. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 66. Asia-Pacific Canine Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 67. Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 68. Asia-Pacific Canine Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 69. South America Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 70. South America Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 71. South America Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 72. South America Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 73. South America Canine Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 74. South America Canine Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 75. South America Canine Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 76. South America Canine Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 77. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 78. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 79. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 80. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 81. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 82. Middle East & Africa Canine Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 83. Middle East & Africa Canine Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 84. Middle East & Africa Canine Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 85. Canine Influenza Vaccine Raw Material
Table 86. Key Manufacturers of Canine Influenza Vaccine Raw Materials
Table 87. Canine Influenza Vaccine Typical Distributors
Table 88. Canine Influenza Vaccine Typical Customers
List of Figures
Figure 1. Canine Influenza Vaccine Picture
Figure 2. Global Canine Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Canine Influenza Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Liquid Examples
Figure 5. Powder Examples
Figure 6. Global Canine Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Canine Influenza Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Home Examples
Figure 9. Pet Clinic Examples
Figure 10. Others Examples
Figure 11. Global Canine Influenza Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Canine Influenza Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Canine Influenza Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 14. Global Canine Influenza Vaccine Average Price (2018-2029) & (USD/Dose)
Figure 15. Global Canine Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Canine Influenza Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Canine Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Canine Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Canine Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Canine Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Canine Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Canine Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Canine Influenza Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Canine Influenza Vaccine Average Price by Type (2018-2029) & (USD/Dose)
Figure 30. Global Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Canine Influenza Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Canine Influenza Vaccine Average Price by Application (2018-2029) & (USD/Dose)
Figure 33. North America Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Canine Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Canine Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Canine Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Canine Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Canine Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Canine Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Canine Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Canine Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Canine Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Canine Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Canine Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Canine Influenza Vaccine Market Drivers
Figure 74. Canine Influenza Vaccine Market Restraints
Figure 75. Canine Influenza Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Canine Influenza Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Canine Influenza Vaccine
Figure 79. Canine Influenza Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Merck Animal Health
Zoetis
CSL Limited
jiaGou

Add To Cart

gouMai

Buy Now